Chromosomal abnormality variation detected by G‐banding is associated with prognosis of diffuse large B‐cell lymphoma treated by R‐CHOP‐based therapy

Abstract Diffuse large B‐cell lymphoma (DLBCL), which is the most prevalent disease subtype of non‐Hodgkin lymphoma, is highly heterogeneous in terms of cytogenetic and molecular features. This study retrospectively investigated the clinical impact of G‐banding‐defined chromosomal abnormality on tre...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Yoshimi Mizuno, Taku Tsukamoto, Eri Kawata, Nobuhiko Uoshima, Hitoji Uchiyama, Isao Yokota, Saori Maegawa, Tomoko Takimoto, Kazuna Tanba, Yayoi Matsumura‐Kimoto, Saeko Kuwahara‐Ota, Yuto Fujibayashi, Mio Yamamoto‐Sugitani, Yoshiaki Chinen, Yuji Shimura, Shigeo Horiike, Masafumi Taniwaki, Tsutomu Kobayashi, Junya Kuroda
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Wiley 2018-03-01
Sarja:	Cancer Medicine
Aiheet:	Chromosomal abnormality chromosomal abnormality variations diffuse large B‐cell lymphoma karyotypic evolution
Linkit:	https://doi.org/10.1002/cam4.1342
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!